Summary
Plasma phospholipid fractions and clinical data were investigated in patients withZieve syndrome. Follow up studies revealed significantly increased levels of lysolecithin and lysocephalin at the beginning of haemolysis. Also connections were found between other clinical data and plasma phospholipid fractions.
Zusammenfassung
Plasmaphospholipidfraktionen und klinische Daten wurden bei Patienten mitZieve-Syndrom untersucht. Verlaufskontrollen zeigten eine signifikante Vermehrung von Lysolecithin und Lysokephalin bei Beginn der Hämolyse. Auch zwischen anderen Phospholipidfraktionen und klinischen Daten wurden Beziehungen gefunden.
Similar content being viewed by others
Abbreviations
- HL:
-
primary hyperlipoproteinaemia, hyperlipoproteinaemic
- HT:
-
primary hypertriglyceridaemia, hypertriglyceridaemic; (type IV hyperlipoproteinaemia)
- LL:
-
lysolecithin (lysophosphatidylcholine)
- SM:
-
sphingomyelin
- L:
-
lecithin (phosphatidylcholine)
- PI:
-
phosphatidylinositol
- PS:
-
phosphatidylserine
- PE:
-
phosphatidylethanolamine
- LPE:
-
lysophosphatidylethanolamine
- LPI:
-
lysophosphatidylinositol
- LPS:
-
lysophosphatidylserine
- LC:
-
lysocephalin, including LPS, LPI and LPE
- PG:
-
phosphatidylglycerol
- TG:
-
triglyceride(s)
- Chol:
-
cholesterol
References
Albrink, J. M. and G. Klatskin: Amer. J. Med.23, 26 (1957).
Bartlett, G. R.: J. Biol. Chem.234, 466 (1959).
Blass, J. P. and H. M. Dean: Amer. J. Med.40, 283 (1966).
Boon, J., R. M. Broekhyuse, P. van Munster and E. Schretlen: Clin. Chim. Acta23, 453 (1969).
Bornens, M.: Bull. Soc. Chim. Biol.50, 591 (1968).
Braunsteiner, H., M. Herbst, S. Sailer and F. Sandhofer: Schweiz. Med. Wschr.97, 698 (1967).
Carlson, L. A.: J. Atheroscler. Res.3, 334 (1963).
Cawein, M. J., A. B. Hagedorn and C. A. Owen: Gastroenterology38, 324 (1960).
Collier, H. B. and H. L. Chen: Can. J. Res. E.28, 289 (1950).
Cornwell, D. G., R. E. Heikkila, R. S. Bar and G. L. Biagi: J. Amer. Oil Chem. Soc.45, 297, (1968).
Dodge, J. T. and G. B. Phillips: J. Lipid Res.8, 667 (1967).
Doizaki, W. M. and L. Zieve: Proc. Soc. Exptl. Biol. Med.129, 182 (1968).
Edmondson, H. A. and I. A. Fields: Arch. Int. Med.69, 177 (1942).
Enser, M. B., F. Kunz, J. Borensztain, L. H. Opie and D. S. Robinson: Biochem. J.104, 306 (1967).
Etienne, J., A. Grüber and J. Polonovski: Bull. Soc. Chim. Biol.49, 1751 (1967).
Folch, J., M. Lees and G. H. S. Stanley: J. biol. Chem.225, 497 (1957).
Fredrickson, D. S., R. I. Levy and R. S. Lees: New Engl. J. Med.276, 34, 94, 148, 215, 273 (1967).
Gadrat, J., L. Douste-Blazy, A. Ribet, J. P. Pascal et J. Frexinos: Presse Méd.75, 789 (1967).
Gjone, E. and A. Mendeloff: Nord. Med.69, 233 (1963).
Greenberger, N. J., F. T. Hatch, G. D. Drummey and K. J. Isselbacher: Medicine45, 161 (1966).
Hagen, P. O., E. Ofstad and E. Amundsen: Scand. J. Gastroent.4 89 (1969).
Holzknecht, F., F. Spöttl, R. Constantini, E. Knapp, M. Herbst and H. Braunsteiner: J. Atheroscler. Res.11, 105 (1970).
Johnson, R. M. and J. M. Lederkeimer: Arch. Biochem. Biophys.35, 340 (1952).
Kashiwagi, H. and R. Amann: Helv. Med. Acta33, 403 (1966).
Kessel, L.: Amer. J. Med.32, 747 (1962).
Kirschmann, Ch., S. Alloof and A. de Vries: Thromb. Diath. Harmorrh.9, 512 (1963).
Klibanski, Ch. and A. de Vries: Biochem. Biophys. Acta70, 167 (1963).
Kunz, F. and D. Kosin: Wien. Klin. Wschr.80, 764 (1968).
Kunz, F. and D. Kosin: Clin. Chim. Acta27, 185 (1970).
Kunz, F., G. Matt and H. Hackl: Atherosclerosis11, 265 (1970).
Lieber, C. S., D. P. Jones, J. Mendelsson and L. M. De Carli: Tr. Ass. Amer. Phys.1, 289 (1963).
Lieber, C. S., N. Spritz and L. M. De Carli: J. Clin. Invest.45, 51 (1966).
Mallow, S. and F. Cerra: J. Pharmac. exp. Ther.156, 426 (1967).
Munder, P. G., E. Ferber und H. Fischer: Z. Naturfschg.20, 1948 (1965).
Myerson, R. M.: Amer. J. Gastroenterology49, 304 (1968).
Patelski, J., D. E. Bowyer, A. N. Howard and G. A. Gresham: J. Atheroscler. Res.8, 221 (1968).
Rubin, E. and C. S. Lieber: New England J. Med.278, 869 (1968).
Rüdiger, H. W., K. G. Blume, H. Esselborn, P. Glogner, H. Kaffarnik, J. Finke und G. W. Löhr: Blut20, 178 (1970).
Saunders, L.: J. Pharm. Pharmacol.9, 834 (1957).
Schmidt, H., W. Creutzfeld und E. Habermann: Klin. Wschr45, 163 (1967).
Searcy, R. L., L. M. Bergquist and R. C. Jung: J. Lipid Res.1, 359 (1960).
Shapiro, R. H. G., G. D. Drummey, Y. Shimizu and K. J. Isselbacher: J. Clin. Invest.43, 1338 (1964).
Switzer, S. and H. E. Eder: J. Lipid Res.6, 506 (1965).
Szeinberg, A., J. Zaidman and L. Clejan: Biochim. Biophys. Acta98, 598 (1965).
Trout, D. L., E. H. Esters and S. J. Friedberg: J. Lipid Res.1, 199 (1960).
Vogel, W. C. and E. L. Bierman: J. Lipid Res8, 46 (1967).
Wanke, M., W. Nagel, M. M. Lindner und H. Sebenig: Z. f. Gastroenterologie6, 434 (1968).
Zieve, L.: Ann. Int. Med.48, 471 (1958)
Zieve, L. and E. Hill: South. Med. J.54, 1347 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kunz, F., Stummvoll, W. The significance of plasma phospholipids inZieve syndrome. Blut 21, 210–226 (1970). https://doi.org/10.1007/BF01632304
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01632304